Stockreport

Gilead Sciences: Caution After A Re-Rating Amidst New Concentration Risks [Seeking Alpha]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF Gilead's growth is increasingly concentrated in its HIV franchise, now nearly three-quarters of product revenue, raising dependency and concentration risks. Recent M& [Read more]